You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high-risk polycythemia vera

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

Not yet recruiting
  • Polycythemia Vera
  • Givinostat Hydrochloride
  • Hydroxy Urea
  • (no location specified)
Oct 19, 2023

Identify and Describe Predictive Factors for Thromboembolic

Not yet recruiting
  • Polycythemia Vera
  • Hydroxyurea
  • Ruxolitinib
  • (no location specified)
Nov 2, 2022

Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

Recruiting
  • Polycythemia Vera
  • London, United Kingdom
  • +1 more
Nov 29, 2021

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021

Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)

Active, not recruiting
  • Polycythemia Vera (PV)
  • Essential Thrombocythemia (ET)
  • Mannheim, Baden-Württemberg, Germany
  • +23 more
Oct 6, 2020

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

Active, not recruiting
  • Polycythemia Vera
  • San Giovanni Rotondo, (FG) Puglia, Italy
  • +22 more
Jan 10, 2023

Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)

Not yet recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Boston, Massachusetts
  • +2 more
Nov 24, 2020

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Ruxolitinib for Polycythemia Vera in Patients Resistant to or

Completed
  • Polycythemia Vera (PV)
  • Ruxolitinib
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Polycythemia Vera Trial in Italy

Recruiting
  • Polycythemia Vera
    • Reggio Calabria, Calabria, Italy
    • +21 more
    Nov 10, 2023

    Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

    Recruiting
    • Polycythemia Vera
      • Sohag, Egypt
        Faculty of Medicine
      Aug 12, 2023

      Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Birmingham, Alabama
      • +151 more
      Aug 22, 2022

      Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

      Not yet recruiting
      • Polycythemia Vera
      • Ropeginterferon alfa-2b-njft (P1101)
      • (no location specified)
      Jul 28, 2022

      High Risk Polycythemia Vera, High Risk Essential Thrombocythemia Trial in Worldwide (PEGASYS, Hydroxyurea, Aspirin)

      Completed
      Has Results
      • High Risk Polycythemia Vera
      • High Risk Essential Thrombocythemia
      • Scottsdale, Arizona
      • +24 more
      Apr 16, 2019

      A Prospective, Non-interventional Study of JAKAVI® Treatment in

      Active, not recruiting
      • Polycythemia Vera
      • Jakavi
      • Reutlingen, Baden Wuerttemberg, Germany
      • +98 more
      May 16, 2023

      HIGH Altitude CArdiovascular REsearch Latin America Population

      Recruiting
      • Hypertension
      • +5 more
      • Exposure to high altitude
      • Lima, Peru
        Universidad Peruana Cayetano Heredia
      May 10, 2021

      Philadelphia Negative Myeloproliferative Tumors Trial

      Not yet recruiting
      • Philadelphia Negative Myeloproliferative Neoplasms
        • (no location specified)
        Jun 5, 2022

        Acute Myeloid Leukemia, MDS, Agnogenic Myeloid Metaplasia Trial in Houston (Dasatinib (BMS-354825))

        Completed
        Has Results
        • Acute Myeloid Leukemia
        • +7 more
        • Dasatinib (BMS-354825)
        • Houston, Texas
          The University of Texas M.D. Anderson Cancer Center
        May 2, 2019

        Ruxolitinib in Patients With Myelofibrosis

        Not yet recruiting
        • Myelofibrosis
        • (no location specified)
        Feb 28, 2023

        Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

        Recruiting
        • Primary Myelofibrosis
        • +2 more
        • Worcester, Massachusetts
        • +16 more
        Oct 31, 2022

        Polycythemia Vera Trial in Hirakata, Izumo, Osaka (PPMX-T003)

        Recruiting
        • Polycythemia Vera
        • Hirakata, Osaka, Japan
        • +2 more
        Nov 14, 2022